Killer T cells surround a cancer cell. Credit: NIH ========================================================= ANSTO has contributed to a comprehensive investigation of a promising type of nanoparticle that could potentially be used for intractable brain cancers in a combined therapy. The study, which was led by Dr. Moeava Tehei and researchers from the University of Wollongong in combination with clinical partners, characterized and evaluated the properties of nanoparticles made from lanthanum manganite, that were doped with silver atoms. The investigators found that the nanoparticles had potential clinical application for their synergistic effects to be used in combination with radiation treatment, hyperthermia (using heat to...